HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

β-elemonic acid inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells through the suppression of JAK2/STAT3/MCL-1 and NF-ĸB signal pathways.

Abstract
Castration-resistant prostate cancer (CRPC) has become a significant problem in the current treatment of prostate cancer (PCa) with the characteristics of high metastatic potential, resistance and easy recurrence. The abnormal activation of JAK2/STAT3/MCL-1 and NF-κB has been confirmed as the main reason for the development of CRPC. We previously found that β-elemonic acid (β-EA) as a natural triterpene has potential anti-inflammatory and anti-osteosarcoma effects with lower toxicity. But it remains unknown whether it had effects on CRPC. The present research in vitro and in vivo systematically investigates anti-cancer effects and mechanisms of β-EA on human CRPC. β-EA treatment resulted in apoptotic cell death in human PCa cells by mitochondrial apoptotic pathways (including up-regulation of cleaved caspase-3, cleaved PARP, and Bax or down-regulation of Bcl-2). Besides, β-EA at relatively lower levels inhibited colony-forming, the migration and invasion potential of PCa cells, indicating its anti-proliferation and anti-metastasis activities. After exploring the potential mechanism, our results suggested that it subsequently inhibited the activation of JAK2/STAT3/MCL-1 and NF-κB signaling pathway by the administration of β-EA. The silencing of NF-κB/p65, JAK2 and STAT3, respectively, increased the sensitivity of the PCa cells to β-EA induced apoptosis. Moreover, β-EA exhibited a strong affinity with its essential proteins JAK2, RELA/p65, NF-κBIα/IκBα by molecular docking analysis. Importantly, β-EA retards tumor growth in a murine xenograft model, consistent with our study in vitro. Taken together, findings from this study reveal for the first time the potential role and mechanisms of β-EA on CRPC.
AuthorsXiaowen Bao, Jianwei Zhu, Chaoxing Ren, Ang Zhao, Mingya Zhang, Zhiming Zhu, Xuanzhao Lu, Yuning Zhang, Xiaotian Li, Xinyu Sima, Jiaqi Li, Qi Zhang, Bo Ma
JournalChemico-biological interactions (Chem Biol Interact) Vol. 342 Pg. 109477 (Jun 01 2021) ISSN: 1872-7786 [Electronic] Ireland
PMID33878321 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Elsevier B.V. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • MCL1 protein, human
  • Myeloid Cell Leukemia Sequence 1 Protein
  • NF-kappa B p50 Subunit
  • NFKB1 protein, human
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Triterpenes
  • beta-elemonic acid
  • JAK2 protein, human
  • Janus Kinase 2
Topics
  • Animals
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Humans
  • Janus Kinase 2 (metabolism)
  • Male
  • Mice, Inbred BALB C
  • Myeloid Cell Leukemia Sequence 1 Protein (metabolism)
  • NF-kappa B p50 Subunit (metabolism)
  • Prostatic Neoplasms, Castration-Resistant (drug therapy)
  • STAT3 Transcription Factor (metabolism)
  • Signal Transduction (drug effects)
  • Triterpenes (pharmacology, therapeutic use)
  • Xenograft Model Antitumor Assays
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: